Quest Diagnostics Joins National ePrescribing Patient Safety Initiati...( Collaboration Expected to Drive P...)

Collaboration Expected to Drive Physician Adoption of Patient-Safety

Technology eRx NOW(TM) Functionality Expanded to Include Quest Diagnostics Care360(TM)

Physician Portal Lab Order and Results Capabilities

LYNDHURST, N.J. and CHICAGO, Oct. 9 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services and a leading developer of healthcare IT solutions that foster better patient care, and Allscripts (Nasdaq: MDRX), the leading provider of clinical software, connectivity and information solutions that physicians use to improve healthcare, today announced that Quest Diagnostics has joined the National ePrescribing Patient Safety Initiative(TM) (NEPSI(TM)), a joint project of dedicated organizations that each play a unique role in resolving the current crisis in preventable medication errors. Additionally, both companies announced that physician users of eRx NOW(TM), the web-based NEPSI electronic prescribing application provided free of charge by Allscripts, will now have access to electronic laboratory orders and results capabilities from Quest Diagnostics at no charge.

The collaboration between Quest Diagnostics and Allscripts adds significant new capabilities to the NEPSI solution. Quest Diagnostics will provide physician users of eRx NOW with access to the electronic laboratory order and results module within its Care360 Physici
'/>"/>